28th May 2021 16:35
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 27 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
5,339,793 | 2.12% | 103,541 | 0.04% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
63,937 | 0.03% | 4,882,255 | 1.94% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
5,403,730 | 2.14% | 4,985,796 | 1.98% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 450 | 10.5600 GBP |
Purchase | 567 | 10.6150 GBP |
Purchase | 672 | 10.6054 GBP |
Purchase | 834 | 10.6098 GBP |
Purchase | 945 | 10.5945 GBP |
Purchase | 1,196 | 10.5900 GBP |
Purchase | 1,288 | 10.5300 GBP |
Purchase | 1,436 | 10.6090 GBP |
Purchase | 1,492 | 10.6048 GBP |
Purchase | 1,869 | 10.5857 GBP |
Purchase | 2,572 | 10.6111 GBP |
Purchase | 2,900 | 10.6200 GBP |
Purchase | 4,177 | 10.5999 GBP |
Purchase | 5,469 | 10.5950 GBP |
Purchase | 5,536 | 10.6181 GBP |
Purchase | 5,708 | 10.5840 GBP |
Purchase | 6,315 | 10.5975 GBP |
Purchase | 7,020 | 10.5985 GBP |
Purchase | 7,220 | 10.5294 GBP |
Purchase | 7,666 | 10.5924 GBP |
Purchase | 8,385 | 10.5699 GBP |
Purchase | 8,539 | 10.5839 GBP |
Purchase | 8,569 | 10.5927 GBP |
Purchase | 28,489 | 10.6000 GBP |
Purchase | 30,512 | 10.5964 GBP |
Purchase | 41,185 | 10.5917 GBP |
Purchase | 55,380 | 10.6100 GBP |
Purchase | 162,018 | 10.5800 GBP |
Purchase | 240,964 | 10.5442 GBP |
Sale | 263 | 10.6100 GBP |
Sale | 295 | 10.6150 GBP |
Sale | 536 | 10.5997 GBP |
Sale | 784 | 10.5846 GBP |
Sale | 1,020 | 10.5771 GBP |
Sale | 1,100 | 10.6200 GBP |
Sale | 1,181 | 10.5768 GBP |
Sale | 1,753 | 10.5299 GBP |
Sale | 1,844 | 10.5871 GBP |
Sale | 2,845 | 10.5923 GBP |
Sale | 3,236 | 10.5802 GBP |
Sale | 3,475 | 10.5900 GBP |
Sale | 3,686 | 10.5957 GBP |
Sale | 3,728 | 10.5987 GBP |
Sale | 4,608 | 10.6052 GBP |
Sale | 4,957 | 10.5563 GBP |
Sale | 6,259 | 10.5925 GBP |
Sale | 7,220 | 10.5300 GBP |
Sale | 15,297 | 10.6099 GBP |
Sale | 42,981 | 10.5807 GBP |
Sale | 61,436 | 10.5727 GBP |
Sale | 80,012 | 10.5795 GBP |
Sale | 103,009 | 10.5800 GBP |
Sale | 150,000 | 10.5874 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
| unit | |||
SWAP | Long | 135 | 10.5700 GBP |
SWAP | Long | 1,753 | 10.5299 GBP |
SWAP | Long | 5,748 | 10.5933 GBP |
SWAP | Long | 5,781 | 10.5806 GBP |
SWAP | Long | 6,526 | 10.5666 GBP |
SWAP | Long | 8,073 | 10.6002 GBP |
SWAP | Long | 13,900 | 10.5300 GBP |
CFD | Long | 17,009 | 10.5709 GBP |
CFD | Short | 15 | 10.5700 GBP |
SWAP | Short | 3,369 | 10.5973 GBP |
CFD | Short | 8,370 | 10.5699 GBP |
SWAP | Short | 37,687 | 10.5389 GBP |
SWAP | Short | 46,546 | 10.5345 GBP |
SWAP | Short | 110,783 | 10.5396 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 28 May 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210528005343/en/
Copyright Business Wire 2021
Related Shares:
BarclaysUDG.L